Y-Intercept (HK)’s Janux Therapeutics JANX Stock Holding History

Y-Intercept (HK)’s Portfolio JANX Stock Details JANX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.02M	Buy	196,487 +56,520	+40%	+$819K	0.06%	473
2026 Q1	$1.95M	Buy	+139,967	New	+$1.92M	0.04%	728
2025 Q4	–	Sell	-9,241	Closed	-$226K	–	1774
2025 Q3	$226K	Sell	9,241 -11,361	-55%	-$277K	0.01%	1450
2025 Q2	$476K	Buy	20,602 +2,769	+16%	+$73K	0.01%	1222
2025 Q1	$481K	Buy	+17,833	New	+$672K	0.03%	712
2024 Q4	–	Sell	-6,971	Closed	-$317K	–	1424
2024 Q3	$317K	Buy	+6,971	New	+$303K	0.02%	995

Other funds holding JANX

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Y-Intercept (HK)'s JANX Position: Q2 2026 in Review

Y-Intercept (HK) increased its Janux Therapeutics (JANX) stake by 40% in Q2 2026, buying an estimated $819K and bringing the position to 196,487 shares worth $3.02M. The position accounts for 0.06% of the portfolio, ranked #473.

Y-Intercept (HK) first reported a position in JANX in Q3 2024 and has held it in 6 quarters since. 198 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

Y-Intercept (HK) held 196,487 shares of Janux Therapeutics worth $3.02M as of Q2 2026.
Y-Intercept (HK) bought 56,520 Janux Therapeutics shares in Q2 2026, an estimated $819K.
Janux Therapeutics made up 0.06% of Y-Intercept (HK)'s portfolio in Q2 2026, its #473 holding.
Y-Intercept (HK) first reported a position in Janux Therapeutics in Q3 2024 and has held it in 6 quarters since.
198 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.